Cooley advised AgroSpheres on its $22 million Series B financing and led intellectual property due diligence in connection with the round. Cooley counsels AgroSpheres with respect to corporate matters and is the architect behind development of the company’s ever-expanding patent portfolio.

AgroSpheres’ biomanufacturing platform enables cost-effective manufacturing and successful field application of novel biological modalities. The unprecedented field success of foliar-applied AgriCell-RNAi technologies has garnered significant industry interest.

“In this unprecedented bear market, food security, environmental footprint, and supply chain resilience are of paramount importance,” said Payam Pourtaheri, founder and CEO of AgroSpheres. “We are thankful for the support from our partners at Lewis & Clark, OAS, Bidra, and Cavallo, as we take significant strides towards our vision of a future built by nature’s technologies and bring our biobased technologies to partners globally.”